Johan van der Vlag, theme Renal disorders has been appointed professor of Immunology of Kidney Diseases and Transplantation at Radboud University/Radboud university medical center, with effect from 1 March 2020.
Johan van der Vlag is an expert in unravelling the molecular and immunological mechanisms underlying kidney disease and transplantation. His research stems from clinical questions and focuses on the development of new diagnostic/prognostic and therapeutic strategies, as well as valorisation of research findings. In addition to his research, he contributes to immunological education at both Radboud university medical center and the Faculty of Science, and he chairs the Examining Board of the Research Master's programme in Molecular Mechanisms of Disease at Radboud university medical center.
About Johan van der VlagJohan van der Vlag (Assen, 1965) studied molecular biology at the University of Groningen. He earned his PhD from the University of Amsterdam in 1994 with his research on molecular microbiology in the Department of Biochemistry. He then worked as a postdoc researcher at the Department of Food Technology at Wageningen University & Research, where he investigated pre- and probiotics in relation to the microbiome. He subsequently spent four years as a researcher in the Biochemistry department at the Swammerdam Institute for Life Sciences, a department of the University of Amsterdam, where he conducted pioneering research into molecular mechanisms that lead to epigenetic changes. Johan van der Vlag has been working at Radboud university medical center since 2000. Initially, he worked as a senior researcher in the Nephrology Research Laboratory, later as head of the Nephrology Research Laboratory and, since 2009, as associate professor of Experimental Nephrology. In 2010–2011, he was the Berlin visiting professor of diabetes in Israel (European Foundation for the Study of Diabetes).
He is a member of the Scientific Council of the Dutch Kidney Foundation, secretary of the science section of the Dutch Federation for Nephrology and coordinator of a number of national and international research consortia (GLYCOREN, GLYCOTREAT). He is also chair of the personal grant committee and advisor to the board of the Kidney Patient Association at Radboud university medical center.
Related news items
Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images22 May 2020
In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.read more
First clinical trial with genetically modified malaria vaccine completed22 May 2020
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.read more
New step in the development of a vaccine against malaria22 May 2020
A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.read more
Retirement of RIMLS Laboratory Assistant Nelly Mulders-Langen19 May 2020
After more than 45 years, Nelly said goodbye to "her" Radboudumc. We are going to miss her dedication and collegiality, but we wish her al the best for the future in good health.read more